International Journal of Colorectal Disease

, Volume 27, Issue 4, pp 459–466

A randomized controlled trial of anorectal biofeedback for constipation

Authors

    • Department of PsychologyRyerson University
  • Janet Waimin Lee
    • School of MedicineDuke University
  • Julia Berian
    • School of MedicineUniversity of Chicago
  • Taryn R. Patterson
    • Department of PsychologyNorth Carolina State University
  • Amanda del Rosario
    • School of MedicineUniversity of Washington
  • Madhulika G. Varma
    • Section of Colorectal SurgeryUniversity of California, San Francisco
Original Article

DOI: 10.1007/s00384-011-1355-9

Cite this article as:
Hart, S.L., Lee, J.W., Berian, J. et al. Int J Colorectal Dis (2012) 27: 459. doi:10.1007/s00384-011-1355-9

Abstract

Purpose

The purposes of this study were: (1) to examine the efficacy of anorectal biofeedback (AB) for constipation compared to a biofeedback control (BC) treatment and (2) to examine the extent to which self-reported childhood sexual/physical abuse predicted biofeedback outcome.

Methods

Twenty-one patients with pelvic floor dyssynergia were randomized to either (1) an AB arm, where patients learned to isolate the anal sphincter using an electromyography probe, or (2) a BC arm that controlled for the nonspecific effects of biofeedback, where patients learned to relax trapezius or temporalis muscles with EMG feedback. Both treatments were delivered by registered nurses for six sessions. Prior to randomization and post-treatment, patients completed the validated Constipation Severity Instrument and two measures of quality of life (QOL), the Irritable Bowel Syndrome-QOL, and the SF-36. Generalized estimating equations examined the within-group and between-group differences over time.

Results

Pre- and post-treatment data were obtained for six AB and nine BC patients. AB patients' overall constipation severity scores decreased by 35.5% (vs. 15.3%), and their obstructive defecation symptom scores decreased by 37.9% (vs. 19.7%) compared to BC. A similar pattern was shown on the IBS-QOL. On the SF-36 Mental Health Composite (MCS), AB scores improved 28.0% compared to BC scores, which worsened 12.7%. Those without (vs. with) a childhood sexual/physical abuse history showed improvement on the MCS post-biofeedback.

Conclusions

While our sample was statistically underpowered, AB produced clinical improvements in constipation severity and QOL.

Keywords

ConstipationAnorectal biofeedbackQuality of lifeClinical trial

Copyright information

© Springer-Verlag 2011